1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
申请人:Cell Pathways, Inc.
公开号:US06455703B2
公开(公告)日:2002-09-24
1,3,6-Trihydro-6-Aza-3-Oxapentalen-2-One Derivatives which have the following formula:
wherein R1, R2, R3, R4, R5, Y, X, m, and n are as defined in the specification.